7KU-24047-78751
2 vaccinations
7 coded responses
17 check-ins
7 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 981 / WA
- Registered
- 2021-04-16
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Registered in v-safe
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Survey response — day 0, dose 1MedDRA: Familial periodic paralysis, Injection site coldness, Injection site paraesthesia, Paraesthesia — Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesFree text: Injection arm paresthesias (cold, tingling); unusual frequency/severity of hypokalemic periodic paralysis episodes, requiring more K than usual to abortMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — days 1–6 daily, dose 1MedDRA: Hypokalaemia, Paralysis, Unevaluable event — Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaFree text: Potassium dose to prevent symptoms increased by about 2x (hypokalemic periodic paralysis)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-19
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-20
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-21
Survey response — days 1–6 daily, dose 1MedDRA: Cough, Dyspnoea — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Dyspnea, coughMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 1Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-04-23
Health check-in — day 7, dose 1Feeling: Good · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-30
Survey response — day 14, dose 1MedDRA: Arthralgia, Cardioversion, Dehydration — Feeling: GoodFree text: Constant mild joint pain. More easily dehydrated.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Dose 2 — Pfizer-BioNTech
-
2021-05-07
Survey response — day 0, dose 2MedDRA: Condition aggravated, Familial periodic paralysis, Pre-existing disease, Vaccine positive rechallenge — Feeling: Good · Site: Pain, Redness · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Increased severity of hypokalemic periodic paralysis symptoms (attacks trigger more easily, need more potassium to abort attack, etc.) Same as with first shot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain, Rash, not including the immediate area around the injection site · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-09
Survey response — days 1–6 daily, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: Worsened control of hypokalemic periodic paralysis symptoms.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-10
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-11
Survey response — days 1–6 daily, dose 2MedDRA: Blood potassium abnormal, Blood potassium decreased, Blood potassium increased — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Finicky potassium levelsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-05-14
- 2021-05-21
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech |
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Injection arm paresthesias (cold, tingling); unusual frequency/severity of hypokalemic periodic paralysis episodes, requiring more K than usual to abort
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Potassium dose to prevent symptoms increased by about 2x (hypokalemic periodic paralysis)
Systemic reaction (other): Dyspnea, cough
Release 8 — day 14, dose 1
Symptoms: Constant mild joint pain. More easily dehydrated.
Release 8 — day 0, dose 2
Systemic reaction (other): Increased severity of hypokalemic periodic paralysis symptoms (attacks trigger more easily, need more potassium to abort attack, etc.) Same as with first shot.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Worsened control of hypokalemic periodic paralysis symptoms.
Systemic reaction (other): Finicky potassium levels
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Cardioversion | ○ | ✓ | ○ |
| SD | Dehydration | ✓ | · | ✓ |
| SRO | Blood potassium abnormal | ✓ | · | ✓ |
| SRO | Blood potassium decreased | ○ | ✓ | ○ |
| SRO | Blood potassium increased | ○ | ✓ | ○ |
| SRO | Condition aggravated | ✓ | ✓ | ✓ |
| SRO | Cough | ✓ | ✓ | ✓ |
| SRO | Dyspnoea | ✓ | ✓ | ✓ |
| SRO | Familial periodic paralysis | ✓ | ✓ | ✓ |
| SRO | Hypokalaemia | · | · | ✓ |
| SRO | Injection site coldness | ○ | ✓ | ○ |
| SRO | Injection site paraesthesia | ○ | ✓ | ○ |
| SRO | Paraesthesia | ✓ | · | ✓ |
| SRO | Paralysis | · | · | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
| SRO | Unevaluable event | ✓ | ✓ | ○ |
| SRO | Vaccine positive rechallenge | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release